Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists: a Review for the General Cardiologist

被引：0
|
作者：
Kershaw V. Patel
Ashish Sarraju
Ian J. Neeland
Darren K. McGuire
机构：
[1] University of Texas Southwestern Medical Center,Division of Cardiology, Department of Internal Medicine
[2] Stanford University,Division of Cardiovascular Medicine and Cardiovascular Institute
来源：
Current Cardiology Reports | 2020年 / 22卷
关键词：
Atherosclerotic cardiovascular disease; Dipeptidyl peptidase-4 inhibitors; Glucagon-like peptide-1 receptor agonists; Heart failure; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists: a Review for the General Cardiologist
    Patel, Kershaw, V
    Sarraju, Ashish
    Neeland, Ian J.
    McGuire, Darren K.
    CURRENT CARDIOLOGY REPORTS, 2020, 22 (10)
  • [2] Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
    Nauck, Michael A.
    Meier, Juris J.
    Cavender, Matthew A.
    Abd El Aziz, Mirna
    Drucker, Daniel J.
    CIRCULATION, 2017, 136 (09) : 849 - U176
  • [3] Cardiovascular Preventing Effects of Dipeptidyl Peptidase-4 Inhibitors: Beyond Glucagon-Like Peptide-1
    Wang, Xi-Mei
    Yang, Yue-Jin
    Wu, Yong-Jian
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (10): : 1551 - 1551
  • [4] Effects of dipeptidyl peptidase-4 inhibitors in a type 2 diabetes patient with failure of glucagon-like peptide-1 receptor agonists
    Wang, Yufan
    Zhao, Li
    Huang, Qianfang
    Peng, Yongde
    JOURNAL OF DIABETES, 2014, 6 (02) : 164 - 166
  • [5] The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
    Drucker, Daniel J.
    Nauck, Michael A.
    LANCET, 2006, 368 (9548): : 1696 - 1705
  • [6] Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: cardiovascular effects in people with diabetes and cardiovascular disease
    Tan, Xi
    Liang, Yuanjie
    Rajpura, Jigar R.
    Yedigarova, Larisa
    Noone, Josh
    Xie, Lin
    Inzucchi, Silvio
    de Havenon, Adam
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [7] Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: cardiovascular effects in people with diabetes and cardiovascular disease
    Xi Tan
    Yuanjie Liang
    Jigar R. Rajpura
    Larisa Yedigarova
    Josh Noone
    Lin Xie
    Silvio Inzucchi
    Adam de Havenon
    Cardiovascular Diabetology, 22
  • [8] Effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on colorectal cancer incidence and its precursors
    Phyo T. Htoo
    John B. Buse
    Mugdha Gokhale
    M. Alison Marquis
    Virginia Pate
    Til Stürmer
    European Journal of Clinical Pharmacology, 2016, 72 : 1013 - 1023
  • [9] Effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on colorectal cancer incidence and its precursors
    Htoo, Phyo T.
    Buse, John B.
    Gokhale, Mugdha
    Marquis, M. Alison
    Pate, Virginia
    Sturmer, Til
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (08) : 1013 - 1023
  • [10] Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials
    Madsbad, Sten
    Krarup, Thure
    Deacon, Carolyn F.
    Holst, Jens J.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2008, 11 (04): : 491 - 499
12345